当前位置: X-MOL 学术Allergy › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Real-world evidence of subcutaneous allergoid immunotherapy in house dust mite-induced allergic rhinitis and asthma
Allergy ( IF 12.4 ) Pub Date : 2020-03-12 , DOI: 10.1111/all.14240
Marek Jutel 1, 2 , Bernd Brüggenjürgen 3 , Hartmut Richter 4 , Christian Vogelberg 5
Affiliation  

The objective of this study was to analyze the effectiveness of allergen immunotherapy (AIT) with an allergoid in the treatment of house dust mites (HDM)‐induced allergic rhinitis and/or asthma based on recent real‐life data. The outcomes were measured using asthma incidence and consumption of corresponding medications as the indicator of persisting symptoms.

中文翻译:

屋尘螨引起的过敏性鼻炎和哮喘的皮下过敏原免疫疗法的真实世界证据

本研究的目的是基于最近的真实数据分析过敏原免疫疗法 (AIT) 与过敏原在治疗屋尘螨 (HDM) 诱发的过敏性鼻炎和/或哮喘中的有效性。使用哮喘发病率和相应药物的消耗量作为持续症状的指标来测量结果。
更新日期:2020-03-12
down
wechat
bug